Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Prasterone

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT01579344Not ApplicableUnknownPrimary

Lacrimal Drainage System Obstruction Associated to Radioactive Iodine Therapy for Thyroid Carcinoma

NCT00001598Phase 2CompletedPrimary

DHEA Treatment for Sjogren's Syndrome

Showing all 2 trials

Research Network

Common Treatments

  • Prasterone1
  • Radioiodine Therapy1

Active Sponsors

  • National Institute of Dental and Craniofacial Research (NIDCR)1
  • Fabricio Lopes da Fonseca1

Top Investigators

Related Conditions

  • Salivary Gland Disease1
  • Xerostomia1
  • Sjogrens Syndrome1

Activity Timeline